WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

GENETIC AND HISTOLOGICAL STUDIES ON EFFECT OF MESENCHYMAL STEM CELL THERAPY ON EXPERIMENTAL RENAL INJURY INDUCED BY CISPLATIN IN MALE ALBINO RATS

*Rokaya H.Shalaby, Laila A.Rashed, Alaa E.Ismail, Naglaa K.Madkour and
Sherien H.Elwakeel

ABSTRACT

Acute kidney injury (AKI) represents a major clinical problem with high mortality and limited treatment protocols. This study was planned to evaluate the therapeutic effectiveness of bone marrow – derived mesenchymal stem cells (BM-MSCs) in a rat model of cisplatininduced AKI. The aim of the present investigation is to determine whether mesenchymal stem cells can restore renal tubular structure and ameliorate cisplatin-induced clastogenesis in the bone marrow cells of rat. The scoring of chromosomal aberrations was undertaken in the current study as markers of clastogenicity. The Study was carried on 36 male white albino rats, of average weight 120-150 gm. The animals were divided into six groups, Group one: - Served as control and received normal saline throughout the experiments. Group two (model control) received a single dose of cisplatin (5 mg/kg interapritoneally) after 5 days. Group three, four, five and six: - Male albino rats with induced ARF received single interapritoneal injection of PKH26 labeled BM-MSCs immediately after induction of renal failure at different time intervals. Serological measurements included serum urea and creatinine, bone marrow preparation for chromosome aberrations were carried out and kidney specimens were processed for H&E. MSCs-treated group exhibited protection against renal injury serologically and histologically. The main result obtained in the present study revealed that cisplatin when given at a single dose of 5 mg/kg cause high incidences of the percentage of total chromosomal aberrations 62.33% and abnormal metaphases in the bone marrow cells of rat. This percentage was reduced nearly to 17.33% after injection with mesenchymal stem cells for 30 days, the reduction was highly significant (P

Keywords: Acute renal failure; chromosome; cisplatin; mesenchymal stem cells; Renal regeneration.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More